Early Convalescent Plasma for High-Risk Outpatients with Covid-19

BACKGROUND: Early administration of convalescent plasma obtained from blood donors who have recovered from coronavirus disease 2019 (Covid-19) may prevent disease progression in acutely ill, high-risk patients with Covid-19. METHODS: In this randomized, multicenter, single-blind trial, we assigned p...

Descripción completa

Detalles Bibliográficos
Autores principales: Korley, Frederick K., Durkalski-Mauldin, Valerie, Yeatts, Sharon D., Schulman, Kevin, Davenport, Robertson D., Dumont, Larry J., El Kassar, Nahed, Foster, Lydia D., Hah, Jennifer M., Jaiswal, Siddartha, Kaplan, Alesia, Lowell, Ezekiel, McDyer, John F., Quinn, James, Triulzi, Darrell J., Van Huysen, Carol, Stevenson, Valerie L.W., Yadav, Kabir, Jones, Christopher W., Kea, Bory, Burnett, Aaron, Reynolds, Joshua C., Greineder, Colin F., Haas, Nathan L., Beiser, David G., Silbergleit, Robert, Barsan, William, Callaway, Clifton W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385553/
https://www.ncbi.nlm.nih.gov/pubmed/34407339
http://dx.doi.org/10.1056/NEJMoa2103784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385553/
https://www.ncbi.nlm.nih.gov/pubmed/34407339
http://dx.doi.org/10.1056/NEJMoa2103784

Ejemplares similares